Company / Current Assets
Vir Biotechnology, Inc. Current Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$514.1M
FY2025
5-year range
$514.1M / $2.5B
FY2021-FY2025
Trend
-50.7%
vs FY2024
Sector context
#114 of 213
Health Care
What the data says
At $514M, Vir Biotechnology, Inc.'s current assets ranks #114 of 213 in the Health Care sector. Current Assets has declined for 3 consecutive years, from $2.5B in FY2022 to $514M in FY2025.
Based on SEC 10-K filings.
$514M in FY2025 with a 5-year CAGR of -7.8%.
Declined from $1.6B to $514M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -41.1%
- 5-Year CAGR
- -7.8%
- 10-Year CAGR
- -
Sector benchmark
#114 of 213 in Health CareTop 54% of 213This company $514.1M Sector average $2.5B
▼
-79.6% below sector average
Key checks
Key Insights
- Vir Biotechnology, Inc.'s current assets has declined for 3 consecutive years.
- 5-year CAGR of -7.8%, indicating a declining trend.
- In FY2025, current assets decreased 50.7% year-over-year.
- Ranks #114 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $514.1M | -50.7% |
| FY2024 | $1.0B | -34.4% |
| FY2023 | $1.6B | -37.0% |
| FY2022 | $2.5B | +61.2% |
| FY2021 | $1.6B | +102.3% |
| FY2020 | $772.4M | +91.7% |
| FY2019 | $403.0M | +242.2% |
| FY2018 | $117.8M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026